Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Choline O-Acetyltransferase (CHAT) (C-Term) antibody

Antigen

Choline O-Acetyltransferase (CHAT)

Synonyms CMS1A, CMS1A2, B230380D24Rik, CT23399, Cat, ChAT, cha, dChAT, l(3)91Cc, DmelCG12345, CG12345, CHAT, ChoAcTase, Ci-ChAT
Epitope
Alternatives

C-Term

Clonality Polyclonal
Host
Alternatives

Rabbit

Application
Alternatives Immunohistochemistry (IHC), Western Blotting (WB)
5 references available
Catalog no. ABIN350209
Quantity 100 µl  (Variants)
Price 413.33 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 7 to 10 Business Days

Additional Information

Alternative name ChAT (choline O-acetyltransferase) (c-terminal region)
Swiss-Prot P32738
Immunogen A synthetic peptide as a part of rat and mouse ChAT (choline O-acetyltransferase) conjugated to an immunogenic carrier protein was used as the immunogen.
Format Lyophilized
Description Cholinergic systems are implicated in numerous neurologic functions. Alteration in some cholinergic neurons may account for the disturbances of Alzheimer disease. The protein encoded by this gene synthesizes the neurotransmitter acetylcholine. Alternative splice variants have been found that contain alternative 5' untranslated exons. Three of the four described splice variants encode identical 69 kDa proteins while one variant encodes both the 69 kDa and a larger 82 kDa protein. Choline acetylase  catalyzes the reversible synthesis of acetylcholine (ACh) from acetyl CoA and choline at cholinergic synapses. CATALYTIC ACTIVITY: Acetyl-CoA + choline = CoA + O-acetylcholine. Defects in CHAT are the cause of familial infantile myasthenia gravis 2 (FIMG2); also known as CMS-EA. FIMG2 patients have myasthenic symptoms since birth or early infancy, negative tests for anti-AChR antibodies, and abrupt episodic crises with increased weakness, bulbar paralysis, and apnea precipitated by undue exertion, fever, or excitement. Inheritance is autosomal recessive. Also known as: CHOACTase, choline acetylase, choline O-acetyltransferase, CMS1A, CMS1A2, B230380D24Rik.
Specificity Appears to be specific for ChAT.

Application Details

Application Notes IHC, WB. A dilution of 1: 300 to 1: 2000 is recommended. The optimal dilution should be determined by the end user.
Purity whole serum
Storage Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
Restrictions For Research Use only

Publications

Publications Ishii, Oda, Ichikawa et al.: "Complementary DNAs for choline acetyltransferase from spinal cords of rat and mouse: nucleotide sequences, expression in mammalian cells, and in situ hybridization." in: Brain research. Molecular brain research, Vol. 7, Issue 2, pp. 151-9, 1990 (PubMed).

Wu, Hersh: "Identification of an active site arginine in rat choline acetyltransferase by alanine scanning mutagenesis." in: The Journal of biological chemistry, Vol. 270, Issue 49, pp. 29111-6, 1996 (PubMed).

Kengaku, Misawa, Deguchi: "Multiple mRNA species of choline acetyltransferase from rat spinal cord." in: Brain research. Molecular brain research, Vol. 18, Issue 1-2, pp. 71-6, 1993 (PubMed).

Cai, Cronin, Engel et al.: "Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders." in: The EMBO journal, Vol. 23, Issue 10, pp. 2047-58, 2004 (PubMed).

Govindasamy, Pedersen, Lian et al.: "Structural insights and functional implications of choline acetyltransferase." in: Journal of structural biology, Vol. 148, Issue 2, pp. 226-35, 2004 (PubMed).